MEA Biopsy Devices Market

MEA Biopsy Devices Market Size (2023 to 2028)

According to our research report, the size of the Middle East and Africa Biopsy Devices Market worth is estimated at USD 153.40 million in 2023 and growing at a CAGR of 7.25%, to reach USD 217.68 million by 2028.

A biopsy is a medical test performed on a tissue or cell to examine, determine, and remove the body's affected tissue. For example, if a patient is suspected of having cancer, a biopsy extracts tissue samples to diagnose and determine cancer. Interventional radiologists perform the procedure to detect cancer, and the end-users of this market are hospitals, diagnostic centers, and other medical clinics.

The biopsy devices market will experience considerable growth over the forecast period driven by the increasing prevalence of cancer cases, growing demand for minimally invasive biopsy procedures, rapidly aging global population.

Factors responsible for restraining the growth of the MEA biopsy devices market include clinical issues in the core needle biopsy, stringent regulation and standards for the use of a biopsy, and increasing complaints regarding the breast cancer screening procedure.

This research report on the MEA Biopsy Devices Market has been segmented & sub-segmented into the following categories:

By Product: 

• Instruments
  • Manual
  • Automated
  • Semi-automated
• Consumables
  • Reagents
  • Kits

By Type: 

• Needle Biopsy
  • core needle biopsy
  • fine-needle biopsy
  • vacuum-assisted biopsy
• Surgical Biopsy
  • Incisional biopsy
  • Excisional biopsy

By Application: 

• Scientific Research
• Medical Diagnosis
• Agricultural Applications
• Genetic Fingerprinting
• Sex Determination

By End User: 

• Pharmaceutical and Biology Industry
• Academic Research Institute
• Contract Research Organizations
• Forensic Labs

By Country: 

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA 

The Middle East & Africa biopsy devices market is estimated to showcase a moderate CAGR during the forecast period. Factors like the common increasing rate of cancer cases in patients are significant factors driving the market growth. In addition, increasing demand for minimally invasive surgeries, steps taken by the government, and the spread of awareness by various health organizations regarding cancer diseases boost the biopsy device's growth during the forecast period. An increasing number of biopsy procedures and an increasing elder people population are the factors expected to surge the growth in the market. UAE, GCC, KSA, Israel, and other countries in this MEA region are the significant contributors in the biopsy devices market over the forecast period.

The UAE biopsy devices market is expected to lead the market in this region. Factors like steps taken by the government in bringing awareness in patients about the biopsy and the devices used during treatment are one factor that bolsters the growth of the market. Also, factors like strict regulations for the product approval of the devices used for the treatment hinder the market growth of the period.

Biopsy Devices Market in South Africa, Israel, and other countries are likely to have considerable growth in the biopsy devices market over the forecast period. Growing healthcare expenditure and research and development activities are expected to bolster the market growth.

Companies playing a dominating role in the MEA Biopsy Devices Market profiled in this report are Medtronic, Leica Biosystems, Hologic Inc., Boston Scientific Corporation, Becton, Cook Medical Inc., C.R. Bard Inc., Mauna Kea Technologies, Ethicon EndoSurgery Inc., Veran Medical Technologies, Dickinson and Company, Fujifilm Medical Systems, MDxHealth, Argon Medical Devices Inc and Intact Medical Corp.